Alinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening
1 other identifier
observational
14,935
1 country
63
Brief Summary
A prospective multicenter interventional study will be conducted to enroll women undergoing routine cervical cancer screening to collect cervical liquid-based cytology (LBC) specimen(s). For all subjects, two cervical specimens will be collected, and one placed into Hologic ThinPrep Pap Test collection kit with PreservCyt Solution (also referred to as ThinPrep specimen) and the other into BD SurePath liquid-based Pap test (also referred to as SurePath specimen). Cytology and HR HPV results will be generated and utilized to determine need for subject referral to colposcopy. Collection of an endocervical curettage (ECC) specimen, and biopsy(ies) if applicable, from women who are referred to colposcopy as a follow up will be conducted according to a standardized protocol. Disease status for each subject will be determined based on cytology, HPV test results, and/or consensus histology review of cervical biopsy specimens.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2021
63 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 5, 2021
CompletedFirst Posted
Study publicly available on registry
February 10, 2021
CompletedStudy Start
First participant enrolled
February 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 16, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 3, 2022
CompletedFebruary 12, 2024
February 1, 2024
1.3 years
February 5, 2021
February 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Disease Progression greater than or equal to (cervical intraepithelial neoplasia) CIN3
Diagnosis of greater than or equal to CIN3 (cervical intraepithelial neoplasia) is based on central pathology review panel histologic result.
Baseline to 12 weeks
Secondary Outcomes (1)
Disease progression greater than or equal to cervical intraepithelial neoplasia (CIN2)
Baseline to 12 weeks
Study Arms (1)
Alinity m HR HPV
The Alinity m HR HPV IUO assay is a qualitative in vitro test that amplifies and detects HR HPV DNA in cervical cells collected in liquid media. The assay can differentiate between HPV 16, HPV 18, HPV 45 and non-HPV 16/18/45 genotypes \[(31/ 33/ 52/ 58) and (35/ 39/ 51/ 56/ 59/ 66/ 68)\].
Interventions
A qualitative in vitro test that amplifies and detects HR HPV DNA in cervical tissue samples.
Eligibility Criteria
Woman who are ≥25 years of age who are high risk humpapillomarius (HPV).
You may qualify if:
- Women is eligible if she meets the following:
- Is 25 years of age or older
- Is attending a participating clinic for routine cervical cancer screening following screening guidelines
- Has an intact cervix
- Is willing and able to provide documented informed consent
- Is willing and able to undergo colposcopy, biopsy, and endocervical curettage (ECC) within 12 weeks (≤ 84 days) from the baseline visit, if required
- Is willing and able to allow collection of two cervical cytology specimens
You may not qualify if:
- A women is ineligible for the study if she meets any of the following criteria:
- Is pregnant at the time of visit or plans to become pregnant within the following 12 weeks
- Has any known medical condition that, in the opinion of the investigator, would result in increased risk of bleeding at biopsy
- Has a known history of excisional or ablative therapy (e.g., LEEP, cone biopsy, cervical laser surgery, or cryotherapy) to the cervix in the last 12 months prior to the baseline visit
- Had a cervical cytology specimen collected within the last 4 months
- Is currently participating in any diagnostic trial for cervical cancer
- Had a complete or partial hysterectomy, either supra cervical or involving removal of the cervix
- Is currently participating or planning to participate in any clinical trial for HPV treatment (for the duration of this study)
- Previous participation in this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Abbott Molecularlead
Study Sites (63)
University of Alabama at Birmingham Hospital
Birmingham, Alabama, 35233, United States
MedPharmics, LLC
Phoenix, Arizona, 85012, United States
Desert Bloom Family Medicine / West Valley Research Clinic, LLC
Phoenix, Arizona, 85031, United States
Quality of Life Medical & Research Centers, LLC
Tucson, Arizona, 85712, United States
Visions Clinical Research
Tucson, Arizona, 85712, United States
Northern California Research
Sacramento, California, 95821, United States
Physicians' Research Options
Lakewood, Colorado, 80228, United States
Planned Parenthood of Southern New England
New Haven, Connecticut, 06511, United States
David I Lubetkin, MD, LLC
Boca Raton, Florida, 33486, United States
Health Awareness INC
Jupiter, Florida, 33458, United States
Health Awareness, Inc.
Jupiter, Florida, 33458, United States
Partners in Womens Health of Jupiter, LLC
Jupiter, Florida, 33458, United States
Altus Research
Lake Worth, Florida, 33416, United States
South Florida Clinical Research
Margate, Florida, 33063, United States
South Miami OB-GYN, Associates, LLC
Miami, Florida, 33143, United States
Health Awareness, Inc.
Port Saint Lucie, Florida, 34952, United States
Physician Care Clinical Research LLC
Sarasota, Florida, 34239, United States
Joyce R. Miller, MD, LLC dba South Miami Womens Health an Elligo Health Research Site
South Miami, Florida, 33143, United States
Comprehensive Clinical Trials, LLC
West Palm Beach, Florida, 33409, United States
Soapstone Center For Clinical Research
Decatur, Georgia, 30034, United States
The Women's Clinic
Boise, Idaho, 83712, United States
Clinical Research Prime
Idaho Falls, Idaho, 83404, United States
Leavitt Women's Healthcare
Idaho Falls, Idaho, 83404, United States
Providea Health Partners, LLC an Elligo Health Research Site
Mokena, Illinois, 60448, United States
Women's Health Advantage
Fort Wayne, Indiana, 46825, United States
Clinical Trials Management, LLC
Covington, Louisiana, 70433, United States
MedPharmics, LLC
Covington, Louisiana, 70433, United States
Newman Comprehensive Obgyn
Covington, Louisiana, 70433, United States
MedPharmics, LLC
Metairie, Louisiana, 70006, United States
NECCR Fall River LLC
Fall River, Massachusetts, 02720, United States
Valley Ob-Gyn Clinic, PC and Elligo Health Research Site
Saginaw, Michigan, 48602, United States
Saginaw Valley Medical Research Group
Saginaw, Michigan, 48604, United States
Planned Parenthood MN-ND-SD
Saint Paul, Minnesota, 55114, United States
MedPharmics
Gulfport, Mississippi, 39503, United States
Meridian Clinical Research
Hastings, Nebraska, 68901, United States
Women's Clinic of Lincoln, PC
Lincoln, Nebraska, 68510, United States
Dr. Nader and Associates
Las Vegas, Nevada, 89030, United States
Rex Garn Mabey
Las Vegas, Nevada, 89128, United States
Capital Health - Lawrence Ob-Gyn Associates PC
Lawrenceville, New Jersey, 08648, United States
Carolina Institute for Clinical Research
Fayetteville, North Carolina, 28304, United States
Eastern Carolina Women's Center
New Bern, North Carolina, 28562, United States
Unified Women's Clinical Research -Raleigh
Raleigh, North Carolina, 27606, United States
Unified Women's Clinical Research- Lyndhurst Clinical Research
Winston-Salem, North Carolina, 27103, United States
Cleveland MacDonald Women's Hospital
Cleveland, Ohio, 44106, United States
Hilltop Obstetrics & Gynecology, Inc.
Franklin, Ohio, 45005, United States
The Ohio State University Obstetrics and Gynecology Worthington
Worthington, Ohio, 43085-2688, United States
The Ohio State University Obstetrics and Gynecology Worthington
Worthington, Ohio, 43085, United States
OB GYN Associates of Erie
Erie, Pennsylvania, 16507, United States
VitaLink Research - Greenville
Greenville, South Carolina, 29615, United States
Tribe Clinical Research dba Mountain View Clinical Research
Greer, South Carolina, 29651, United States
Medical Research Center of Memphis, LLC
Memphis, Tennessee, 38120, United States
Women's Health Texas, LLC (Elligo)
Austin, Texas, 78705, United States
Hill Country OB/GYN Associates
Austin, Texas, 78748, United States
Austin Area Obgyn, PLLC
Austin, Texas, 78758, United States
Christina Sebestyen MD, P.A. dba OBGYN North
Austin, Texas, 78758, United States
Nueces County Women's Clinic dba Corpus Christi Women's Clinic an Elligo Health Research Site
Corpus Christi, Texas, 78412, United States
Advanced Research Associates
Corpus Christi, Texas, 78414, United States
Ventavia Research Group
Fort Worth, Texas, 76104, United States
TMC Life Research, Inc.
Houston, Texas, 77054, United States
Cedar Health Research, LLC_Avacare West
Irving, Texas, 75062, United States
Medical Colleagues of Texas, LLP
Katy, Texas, 77450, United States
Physicians Research Options
Draper, Utah, 84020, United States
Tidewater Clinical Research Inc
Norfolk, Virginia, 23502, United States
Biospecimen
Tissue sample
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 5, 2021
First Posted
February 10, 2021
Study Start
February 16, 2021
Primary Completion
June 16, 2022
Study Completion
November 3, 2022
Last Updated
February 12, 2024
Record last verified: 2024-02